SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-037648
Filing Date
2024-03-28
Accepted
2024-03-28 09:08:13
Documents
73
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K tlis-20231231.htm   iXBRL 10-K 2713721
2 EX-10.24 tlis-ex10_24.htm EX-10.24 18514
3 EX-19.1 tlis-ex19_1.htm EX-19.1 143079
4 EX-23.1 tlis-ex23_1.htm EX-23.1 6511
5 EX-31.1 tlis-ex31_1.htm EX-31.1 11476
6 EX-31.2 tlis-ex31_2.htm EX-31.2 11622
7 EX-32.1 tlis-ex32_1.htm EX-32.1 7971
8 EX-32.2 tlis-ex32_2.htm EX-32.2 8264
  Complete submission text file 0000950170-24-037648.txt   8994930

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT tlis-20231231.xsd EX-101.SCH 1290741
76 EXTRACTED XBRL INSTANCE DOCUMENT tlis-20231231_htm.xml XML 1163246
Mailing Address 1100 ISLAND DRIVE SUITE 101 REDWOOD CITY CA 94065
Business Address 1100 ISLAND DRIVE SUITE 101 REDWOOD CITY CA 94065 650-433-3000
Talis Biomedical Corp (Filer) CIK: 0001584751 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40047 | Film No.: 24793907
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)